Back to Search

JUSTIN PALARDY, MD

MD

Military Health Care Provider

NPI: 1467198770Individual

Specialties, Licenses & Credentials

General Practice Physician

General Practice

Code: 208D00000X

0101279294(VA)
Military Health Care ProviderPrimary

Military Health Care Provider

Code: 171000000X

0101279294(VA)

Research & Publications (18)

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
PMID 18042296·Crit Care·2007
4-observational
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis.
PMID 17205024·Crit Care Med·2007
8-other
WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock.
PMID 16755255·Crit Care Med·2006
7-preclinical
Heterotrophic plasticity and resilience in bleached corals.
PMID 16641995·Nature·2006
7-preclinical
The activity of pathway-selective estrogen receptor ligands in experimental septic shock.
PMID 16317384·Shock·2005
7-preclinical
Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
PMID 16288370·J Infect Dis·2005
7-preclinical
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.
PMID 16041026·Infect Immun·2005
7-preclinical
Chloroquine enhances survival in Bacillus anthracis intoxication.
PMID 15478072·J Infect Dis·2004
7-preclinical
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects.
PMID 14575770·Vaccine·2003
3-trial
Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis.
PMID 12964125·J Infect Dis·2003
3-trial
Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
PMID 12627007·Crit Care Med·2003
4-observational
Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis.
PMID 12508148·J Infect Dis·2003
7-preclinical
Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
PMID 11521079·J Endotoxin Res·2001
7-preclinical
Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection.
PMID 11303727·Shock·2001
7-preclinical
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
PMID 11237833·J Infect Dis·2001
7-preclinical
The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis.
PMID 11176151·Crit Care Med·2001
7-preclinical
Differential antibiotic-induced endotoxin release in severe melioidosis.
PMID 10720525·J Infect Dis·2000
3-trial
Recombinant human interleukin-11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection.
PMID 10669370·J Infect Dis·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
620 JOHN PAUL JONES CIR, NAVAL MEDICAL CENTER
PORTSMOUTH, VA 23708

Location

Practice Location

620 JOHN PAUL JONES CIR, PORTSMOUTH, VA
(757) 953-5000

Quick Facts

NPI
1467198770
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
18

Are you this provider?

Claim Your Profile